Citbose GM 2mg/500mg/0.2mg Tablet SR
Marketer
Dolchem Pharmaceuticals Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Citbose GM 2mg/500mg/0.2mg Tablet SR
Diabetol-GM 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabetol-GM should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are vital for prevention. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Citbose GM 2mg/500mg/0.2mg Tablet SR
No text was provided. Please provide the text you wish me to rephrase.
Uses of Citbose GM 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Citbose GM 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Citbose GM 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet on an empty stomach.
Common Side effects of Citbose GM 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Citbose GM 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Citbose GM 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Citbose GM 2mg/500mg/0.2mg Tablet SR works:
Extended-release Citbose GM tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Citbose GM 2mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Citbose GM 2mg/500mg/0.2mg tablet might pose pregnancy risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Citbose GM 2mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Citbose GM 2mg/500mg/0.2mg sustained-release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Citbose GM 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; however, it's contraindicated in cases of severe liver disease.
What if you forget to take Citbose GM 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Citbose GM 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citbose GM 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently